January 30, 2012 05:00 AM Eastern Time
RBCC Explores New Cures for Cancer, Brain Injuries & Headaches
NOKOMIS, Fla.--(BUSINESS WIRE)--Cutting-edge stem cell research is producing new breakthroughs that could potentially revolutionize the treatment of currently incurable diseases from cancer to brain injuries to headaches. Rainbow Coral Corp. (OTCBB:RBCC), an emerging biotechnology company, is hard at work identifying and targeting promising new stem-cell treatments for commercialization.
As the world’s population ages and the economic might of emerging countries such as China and India blossoms, the market is increasing daily for new and effective cures to old ailments. RBCC plans to capitalize on recent growth in the biosciences sector by commercializing advanced-stage research with the potential to produce new treatments.
RBCC is aiming high. The company’s current target, n3D Biosciences, has developed a breakthrough cell-culturing system that allows scientists to grow 3D stem cells that behave much more similarly to cells found in the body. This product may directly assist with advanced discoveries to find cures for common injuries and diseases.
With the help of its new allies in BioHouston, RBCC plans to identify new targets on the cutting-edge of biotechnology for acquisition and joint venture.
Through its biotech division, Rainbow BioSciences, RBCC is working to develop new medical and research technology innovations to compete alongside companies such as Cell Therapeutics, Inc.(NASDAQ: CTIC), Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Elan Corp. (NYSE: ELN).
For more information on Rainbow BioSciences’ biotechnology initiative, please visit www.rainbowbiosciences.com/investors.
http://www.businesswire.com/news/home/20120130005469/en/RBCC-Explores-Cures-Cancer-Brain-Injuries-Headaches